AdaptHealth Corp. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023
For the full year, sales was USD 3,200.18 million compared to USD 2,970.6 million a year ago. Net loss was USD 678.9 million compared to net income of USD 69.32 million a year ago. Basic loss per share from continuing operations was USD 5.06 compared to basic earnings per share from continuing operations of USD 0.47 a year ago. Diluted loss per share from continuing operations was USD 5.31 compared to diluted earnings per share from continuing operations of USD 0.33 a year ago.